A recent study in a rabbit model of HFD-induced metabolic syndrome indicated that long-term treatment with INT-767 decreased HFD-induced fatty acid synthesis and fibrosis, while increasing lipid handling and improving insulin resistance (Comeglio et al., 2018). The gene discussed is INS; the disease is metabolic syndrome.